Navigating Experience and Possibilities with Subcutaneous Infliximab as a Biobetter in IBD (Celltrion Healthcare)
Edoardo Vincenzo Savarino 1
Anthony Buisson 2
Axel Dignass 3
1 University of Padua, Division of Gastroenterology
2 CHU Estaing Clermont-Ferrand
3 Agaplesion Markus Hospital, Goethe University
Conference
UEG Week 2022
Publisher
Login to access library content
Do you need help setting up your myUEG account?
Contact us at [email protected]